Initially, hair care products such as Vatika hair oil and shampoos, Meswak toothpaste, Chyawanprash and honey would be made available.
The race to acquire diversified fintech firm Religare Enterprise Limited (REL) intensified as Dabur group promoters, the Burman family, said it was going ahead with the open offer on Monday and claimed that the counter offer made by US-based businessman Digvijay Gaekwad wasn't valid and will not stand scrutiny of market regulator Sebi. The Burman family claimed that the competing offer falls outside the 15-day window stipulated by the Sebi takeover code, following their initial offer on October 4th, 2023.
Fast-moving consumer goods (FMCG) companies are expected to witness pressure on volumes in the October-December quarter. However, price hikes will help push up revenues, said brokerages.For India's largest engineering firm, Larsen and Toubro (L&T), the analysts expect a 20 per cent growth in consolidated revenue, and an 8.1 per cent core business Ebitda margin, up 40 bps from a year ago.
Fem Care is a good addition to the portfolio because Dabur didn't have a presence in the skin care space. What Fem Care brings to the table is a strong product portfolio -- comprising bleaches, hair removing creams and liquid soaps -- which is complementary to Dabur's Gulabari skin-care range.
Mohit Burman, the youngest among the newly appointed corporate heads among Dabur businesses, is known to have a penchant for acquisitions.
Leading FMCG companies reported a decline in margins in the September quarter on account of higher input costs and food inflation, which ultimately slowed down the pace of urban consumption. Rising prices of commodity inputs such as palm oil, coffee and cocoa were also accentuated and some FMCG firms have hinted at a price hike. HUL, Godrej Consumer Products Ltd (GCPL), Marico, ITC, and Tata Consumer Products Ltd (TCPL) have expressed concerns over squeezing urban consumption, which according to industry experts forms 65-68 per cent of FMCG total sales.
Dabur has successfully transformed itself from a company known for its health supplement, Chyawanprash, to a multi-product, fast moving consumer goods (FMCG) player.
After Bangladesh, Dabur India is eyeing Pakistan for establishing an equity joint venture with a local company Fisher and Mul, in line with plans to go global.
In its endeavour to turn global, Dabur India on Monday said it has entered into a 74:26 joint venture with Bangladeshi company Advanced Chemical Industries for producing hair and oral care items.
After being cornered by Patanjali and macro-headwinds, ayurveda major Dabur is pulling up its socks. With better sales and improved margins, the firm is now looking to leverage the renewed popularity of ayurveda, mostly ignited by rival Patanjali. Sunil Duggal, bottom, left, chief executive officer, Dabur India, shares his plans and insights with Arnab Dutta.
Dabur Pharma, a leading player in the domestic oncology segment, is busy finalising its marketing strategies for EU, the US and Australia.
Dabur Pharma has sold its entire non-oncology business to Alembic for approximately Rs 167 crore
... resulting in a Rs 2 trillion economic spinoff.
A source with knowledge of the matter claimed Dabur might have already approached the two companies, without revealing further details.
Religare Enterprises, a financial services firm, has disclosed that the Reserve Bank of India (RBI) turned down its application to appoint Rakesh Asthana as its whole-time director in May this year without citing any reasons. Asthana is a former top official of the Central Bureau of Investigation (CBI). In a notice to the stock exchanges, Religare said that while the company and Asthana were weighing the options of dealing with the letter of refusal by the RBI, it was also busy in preparing for the "herculean task" of making ready multiple applications to regulators.
Dabur Foods said on Thursday that it was eyeing to more than double sales turnover at Rs 200 crore (Rs 2 billion) in two years on the back of increasing sales of fruit-based beverages.
Dabur gets nearly a third of its Rs 2,900-crore international sales from Africa
Dabur India Ltd has sold its entire stake in its French cheese-making joint venture, Dabon International Pvt.
To shed its mass market tag, Dabur to focus on health juices rather than fruit drinks. While the pharma sector in India may be looking up, for the Dabur Group, the move is in line with its desire to maintain a strong foothold in the FMCG sector that is poised to grow by 16 per cent this financial year compared to the 12 per cent growth rate in pharma.
In a move to focus on its core FMCG strength, the Burman family, promoters of Dabur India, last week announced their exit from the pharma business.
The FMCG industry hopes for a revival in consumption growth in 2025 with some 'green shoots' already visible, after having a challenging year amid escalating input costs and a double-digit rise in food inflation, which ultimately slowed down the pace of the urban market growth in the second half of 2024. Soaring prices of commodities such as palm oil, coffee, cocoa and wheat forced FMCG players to go for a hike of 3 to 5 per cent or resort to shrinkflation by reducing pack sizes and grammage to retain attractive price points, fearing a volume loss.
As part of its global expansion plans, Dabur Pharma has acquired the sales and distribution network of Thailand-based Bioscience for an undisclosed sum.
FMCG major Dabur India has decided to hold back the expansion plan of its newly launched retail arm with an aim of capitalising more from further downslide in retail rentals that the company is expecting.
Dabur is piggybacking on the equity of its digestive brand Hajmola to enter a new segment in confectionery - mints.
Equity investors will track the trading activity of foreign investors, global trends and ongoing earnings results for further cues, and benchmark indices may continue to witness consolidation in a holiday-shortened week amid the monthly derivatives expiry, analysts said. Markets fell sharply last week amid massive foreign capital outflows and dismal Q2 earnings so far. Weakness in the markets might continue in the near term amid cautiousness among investors ahead of the US presidential election early next month, an expert said.
Although the school, through an oral submission, defended the use of the banyan tree, it has not been able to convince Justice Pradeep Nandrajog, who is hearing the case.
H&B's lifestyle retail arm, which will operate under the brand name 'new-u', marks the entry of Dabur into modern retail. The first new-u retail outlet is scheduled to open in January next year in Delhi and later expand to other major cities across India.
Dabur India's brand proliferation contrasts starkly with other FMCG companies' power brands. How effective will the strategy be?
Dabur Pharma launched its new nano technology-based chemotherapy agent Nanoxel in the country on Thursday.
Homegrown FMCG major Dabur India on Wednesday outlined a four-year business plan involving an aggressive expansion strategy in the domestic and foreign markets, including new product launches and acquisitions
FMCG firm Dabur India on Monday signed cricketer Virender Sehwag and his wife Arti as brand ambassadors for select oral, hair and healthcare products.
Dabur India on Wednesday said it was in talks with three firms to acquire their brands, while also acquiring a brand from its sister concern Dabur Pharma and introducing more products this fiscal.
According to the latest shareholding pattern of Dabur, Pradip Burman, who is part of the promoter group, holds 0.02 per cent stake in the company.
Dabur India on Monday filed its scheme of demerger of the pharma and MNC businesses in the Delhi high court, after its board of directors approved the proposal.
Having bought over the promoters' stake in Balsara, homegrown FMCG major Dabur India said on Monday it would make an offer to other shareholders for buying out the residual equity.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances